Park So-Young, Nguyen Phi-Hung, Kim Gahyun, Jang Su-Nyeong, Lee Ga-Hyun, Phuc Nguyen Minh, Wu Zhexue, Liu Kwang-Hyeon
BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.
Pharmaceutics. 2020 Apr 10;12(4):343. doi: 10.3390/pharmaceutics12040343.
Like flavonoids, biflavonoids, dimeric flavonoids, and polyphenolic plant secondary metabolites have antioxidant, antibacterial, antiviral, anti-inflammatory, and anti-cancer properties. However, there is limited data on their effects on cytochrome P450 (P450) and uridine 5'-diphosphoglucuronosyl transferase (UGT) enzyme activities. In this study we evaluate the inhibitory potential of five biflavonoids against nine P450 activities (P450s1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A) in human liver microsomes (HLMs) using cocktail incubation and liquid chromatography-tandem mass spectrometry (LC-MS/MS). The most strongly inhibited P450 activity was CYP2C8-mediated amodiaquine -dealkylation with IC50 ranges of 0.019~0.123 μM. In addition, the biflavonoids-selamariscina A, amentoflavone, robustaflavone, cupressuflavone, and taiwaniaflavone-noncompetitively inhibited CYP2C8 activity with respective values of 0.018, 0.083, 0.084, 0.103, and 0.142 μM. As selamariscina A showed the strongest effects, we then evaluated it against six UGT isoforms, where it showed weaker inhibition (UGTs1A1, 1A3, 1A4, 1A6, 1A9, and 2B7, IC50 1.7 μM). Returning to the P450 activities, selamariscina A inhibited CYP2C9-mediated diclofenac hydroxylation and tolbutamide hydroxylation with respective values of 0.032 and 0.065 μM in a competitive and noncompetitive manner. However, it only weakly inhibited CYP1A2, CYP2B6, and CYP3A with respective values of 3.1, 7.9, and 4.5 μM. We conclude that selamariscina A has selective and strong inhibitory effects on the CYP2C8 and CYP2C9 isoforms. This information might be useful in predicting herb-drug interaction potential between biflavonoids and co-administered drugs mainly metabolized by CYP2C8 and CYP2C9. In addition, selamariscina A might be used as a strong CYP2C8 and CYP2C9 inhibitor in P450 reaction-phenotyping studies to identify drug-metabolizing enzymes responsible for the metabolism of new chemicals.
与类黄酮一样,双黄酮、二聚体类黄酮和多酚类植物次生代谢产物具有抗氧化、抗菌、抗病毒、抗炎和抗癌特性。然而,关于它们对细胞色素P450(P450)和尿苷5'-二磷酸葡萄糖醛酸基转移酶(UGT)酶活性影响的数据有限。在本研究中,我们使用鸡尾酒孵育法和液相色谱-串联质谱法(LC-MS/MS)评估了五种双黄酮对人肝微粒体(HLM)中九种P450活性(P450s1A2、2A6、2B6、2C8、2C9、2C19、2D6、2E1和3A)的抑制潜力。受抑制最强的P450活性是CYP2C8介导的阿莫地喹脱烷基化,IC50范围为0.019~0.123μM。此外,双黄酮——海金沙双黄酮A、穗花杉双黄酮、粗榧双黄酮、扁柏双黄酮和台湾双黄酮——以各自0.018、0.083、0.084、0.103和0.142μM的值非竞争性抑制CYP2C8活性。由于海金沙双黄酮A显示出最强的作用,我们随后评估了它对六种UGT同工型的作用,结果显示其抑制作用较弱(UGTs1A1、1A3、1A4、1A6、1A9和2B7,IC50为1.7μM)。再回到P450活性方面,海金沙双黄酮A以竞争性和非竞争性方式分别以0.032和0.065μM的值抑制CYP2C9介导的双氯芬酸羟基化和甲苯磺丁脲羟基化。然而,它对CYP1A2、CYP2B6和CYP3A的抑制作用较弱,各自的值分别为3.1、7.9和4.5μM。我们得出结论,海金沙双黄酮A对CYP2C8和CYP2C9同工型具有选择性和强烈的抑制作用。该信息可能有助于预测双黄酮与主要由CYP2C8和CYP2C9代谢的联合用药之间的药草-药物相互作用潜力。此外,在P450反应表型研究中,海金沙双黄酮A可能用作一种强效的CYP2C8和CYP2C9抑制剂,以鉴定负责新化学物质代谢的药物代谢酶。